Cellular mechanisms of tumour suppression by the retinoblastoma gene - PubMed (original) (raw)

• p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications.
  Benitez DA, Cumplido-Laso G, Olivera-Gómez M, Del Valle-Del Pino N, Díaz-Pizarro A, Mulero-Navarro S, Román-García A, Carvajal-Gonzalez JM. Benitez DA, et al. Biomedicines. 2024 Jun 29;12(7):1453. doi: 10.3390/biomedicines12071453. Biomedicines. 2024. PMID: 39062026 Free PMC article. Review.
• In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors.
  Pesini C, Artal L, Paúl Bernal J, Sánchez Martinez D, Pardo J, Ramírez-Labrada A. Pesini C, et al. Oncoimmunology. 2024 Jul 18;13(1):2379062. doi: 10.1080/2162402X.2024.2379062. eCollection 2024. Oncoimmunology. 2024. PMID: 39036370 Free PMC article. Review.
• APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest.
  Mouery BL, Baker EM, Mei L, Wolff SC, Mills CA, Fleifel D, Mulugeta N, Herring LE, Cook JG. Mouery BL, et al. Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2319574121. doi: 10.1073/pnas.2319574121. Epub 2024 Jul 18. Proc Natl Acad Sci U S A. 2024. PMID: 39024113
• Exploring the Potential Role of Phytopharmaceuticals in Alleviating Toxicities of Chemotherapeutic Agents.
  Katolkar UN, Surana SJ. Katolkar UN, et al. Curr Protein Pept Sci. 2024;25(10):753-779. doi: 10.2174/0113892037307940240606075208. Curr Protein Pept Sci. 2024. PMID: 38919003 Review.
• Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.
  Saner FAM, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, Fereday S, Twomey L, Pishas KI, Hoang T, Bolithon A, Traficante N; Australian Ovarian Cancer Study Group; Alsop K, Christie EL, Kang EY, Nelson GS, Ghatage P, Lee CH, Riggan MJ, Alsop J, Beckmann MW, Boros J, Brand AH, Brooks-Wilson A, Carney ME, Coulson P, Courtney-Brooks M, Cushing-Haugen KL, Cybulski C, El-Bahrawy MA, Elishaev E, Erber R, Gayther SA, Gentry-Maharaj A, Gilks CB, Harnett PR, Harris HR, Hartmann A, Hein A, Hendley J, Hernandez BY, Jakubowska A, Jimenez-Linan M, Jones ME, Kaufmann SH, Kennedy CJ, Kluz T, Koziak JM, Kristjansdottir B, Le ND, Lener M, Lester J, Lubiński J, Mateoiu C, Orsulic S, Ruebner M, Schoemaker MJ, Shah M, Sharma R, Sherman ME, Shvetsov YB, Soong TR, Steed H, Sukumvanich P, Talhouk A, Taylor SE, Vierkant RA, Wang C, Widschwendter M, Wilkens LR, Winham SJ, Anglesio MS, Berchuck A, Brenton JD, Campbell I, Cook LS, Doherty JA, Fasching PA, Fortner RT, Goodman MT, Gronwald J, Huntsman DG, Karlan BY, Kelemen LE, Menon U, Modugno F, Pharoah PDP, Schildkraut JM, Sundfeldt K, Swerdlow AJ, Goode EL, DeFazio A, Köbel M, Ramus SJ, Bowtell DDL, Garsed DW. Saner FAM, et al. Clin Cancer Res. 2024 Aug 15;30(16):3481-3498. doi: 10.1158/1078-0432.CCR-23-3552. Clin Cancer Res. 2024. PMID: 38837893 Free PMC article.